id	sid	tid	token	lemma	pos
work_l7e6s5xjjrez3dcffje2smkysi	1	1	RP-3-765.pmd	RP-3-765.pmd	NNP
work_l7e6s5xjjrez3dcffje2smkysi	1	2	T	T	NNP
work_l7e6s5xjjrez3dcffje2smkysi	1	3	he	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	1	4	most	most	RBS
work_l7e6s5xjjrez3dcffje2smkysi	1	5	commonly	commonly	RB
work_l7e6s5xjjrez3dcffje2smkysi	1	6	used	use	VBD
work_l7e6s5xjjrez3dcffje2smkysi	1	7	drugs	drug	NNS
work_l7e6s5xjjrez3dcffje2smkysi	1	8	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	1	9	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	1	10	treatment	treatment	NN
work_l7e6s5xjjrez3dcffje2smkysi	1	11	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	1	12	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	1	13	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	1	14	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	1	15	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	1	16	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	1	17	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	1	18	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	1	19	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	2	1	Children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	2	2	exposed	expose	VBN
work_l7e6s5xjjrez3dcffje2smkysi	2	3	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	2	4	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	2	5	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	2	6	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	2	7	prolonged	prolonged	JJ
work_l7e6s5xjjrez3dcffje2smkysi	2	8	period	period	NN
work_l7e6s5xjjrez3dcffje2smkysi	2	9	may	may	MD
work_l7e6s5xjjrez3dcffje2smkysi	2	10	experience	experience	VB
work_l7e6s5xjjrez3dcffje2smkysi	2	11	adverse	adverse	JJ
work_l7e6s5xjjrez3dcffje2smkysi	2	12	effects	effect	NNS
work_l7e6s5xjjrez3dcffje2smkysi	2	13	such	such	JJ
work_l7e6s5xjjrez3dcffje2smkysi	2	14	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	2	15	growth	growth	NN
work_l7e6s5xjjrez3dcffje2smkysi	2	16	failure	failure	NN
work_l7e6s5xjjrez3dcffje2smkysi	2	17	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	2	18	infections	infection	NNS
work_l7e6s5xjjrez3dcffje2smkysi	2	19	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	2	20	hypertension	hypertension	NN
work_l7e6s5xjjrez3dcffje2smkysi	2	21	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	2	22	osteoporosis	osteoporosis	NN
work_l7e6s5xjjrez3dcffje2smkysi	2	23	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	3	1	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	3	2	order	order	NN
work_l7e6s5xjjrez3dcffje2smkysi	3	3	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	3	4	reduce	reduce	VB
work_l7e6s5xjjrez3dcffje2smkysi	3	5	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	3	6	toxicity	toxicity	NN
work_l7e6s5xjjrez3dcffje2smkysi	3	7	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	3	8	alternative	alternative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	3	9	drugs	drug	NNS
work_l7e6s5xjjrez3dcffje2smkysi	3	10	such	such	JJ
work_l7e6s5xjjrez3dcffje2smkysi	3	11	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	3	12	cyclophosphamide	cyclophosphamide	JJ
work_l7e6s5xjjrez3dcffje2smkysi	3	13	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	3	14	cyclosporine	cyclosporine	NN
work_l7e6s5xjjrez3dcffje2smkysi	3	15	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	3	16	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	3	17	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	3	18	used	use	VBN
work_l7e6s5xjjrez3dcffje2smkysi	3	19	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	3	20	1,2	1,2	CD
work_l7e6s5xjjrez3dcffje2smkysi	3	21	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	3	22	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	4	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	4	2	is	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	4	3	an	an	DT
work_l7e6s5xjjrez3dcffje2smkysi	4	4	immunomodulator	immunomodulator	NN
work_l7e6s5xjjrez3dcffje2smkysi	4	5	that	that	WDT
work_l7e6s5xjjrez3dcffje2smkysi	4	6	has	have	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	4	7	been	be	VBN
work_l7e6s5xjjrez3dcffje2smkysi	4	8	used	use	VBN
work_l7e6s5xjjrez3dcffje2smkysi	4	9	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	10	more	more	JJR
work_l7e6s5xjjrez3dcffje2smkysi	4	11	than	than	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	12	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	4	13	decades	decade	NNS
work_l7e6s5xjjrez3dcffje2smkysi	4	14	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	4	15	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	4	16	is	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	4	17	often	often	RB
work_l7e6s5xjjrez3dcffje2smkysi	4	18	used	use	VBN
work_l7e6s5xjjrez3dcffje2smkysi	4	19	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	20	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	4	21	first	first	JJ
work_l7e6s5xjjrez3dcffje2smkysi	4	22	option	option	NN
work_l7e6s5xjjrez3dcffje2smkysi	4	23	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	24	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	4	25	treatment	treatment	NN
work_l7e6s5xjjrez3dcffje2smkysi	4	26	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	27	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	4	28	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	4	29	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	4	30	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	4	31	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	4	32	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	4	33	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	4	34	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	4	35	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	4	36	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	5	1	Its	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	5	2	major	major	JJ
work_l7e6s5xjjrez3dcffje2smkysi	5	3	advantages	advantage	NNS
work_l7e6s5xjjrez3dcffje2smkysi	5	4	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	5	5	steroid	steroid	JJ
work_l7e6s5xjjrez3dcffje2smkysi	5	6	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	5	7	sparing	spare	VBG
work_l7e6s5xjjrez3dcffje2smkysi	5	8	property	property	NN
work_l7e6s5xjjrez3dcffje2smkysi	5	9	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	5	10	less	less	JJR
work_l7e6s5xjjrez3dcffje2smkysi	5	11	toxicity	toxicity	NN
work_l7e6s5xjjrez3dcffje2smkysi	5	12	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	5	13	comparison	comparison	NN
work_l7e6s5xjjrez3dcffje2smkysi	5	14	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	5	15	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	5	16	other	other	JJ
work_l7e6s5xjjrez3dcffje2smkysi	5	17	immunosuppresants	immunosuppresant	NNS
work_l7e6s5xjjrez3dcffje2smkysi	5	18	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	5	19	3	3	CD
work_l7e6s5xjjrez3dcffje2smkysi	5	20	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	5	21	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	6	1	This	this	DT
work_l7e6s5xjjrez3dcffje2smkysi	6	2	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	3	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	6	4	conducted	conduct	VBN
work_l7e6s5xjjrez3dcffje2smkysi	6	5	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	6	6	evaluate	evaluate	VB
work_l7e6s5xjjrez3dcffje2smkysi	6	7	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	6	8	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	9	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	6	10	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	11	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	6	12	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	13	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	6	14	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	6	15	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	6	16	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	17	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	6	18	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	6	19	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	6	20	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	6	21	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	6	22	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	6	23	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	6	24	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	6	25	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	6	26	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	6	27	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	6	28	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	6	29	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	6	30	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	7	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	7	2	specific	specific	JJ
work_l7e6s5xjjrez3dcffje2smkysi	7	3	objectives	objective	NNS
work_l7e6s5xjjrez3dcffje2smkysi	7	4	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	7	5	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	7	6	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	7	a	a	LS
work_l7e6s5xjjrez3dcffje2smkysi	7	8	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	9	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	7	10	determine	determine	VB
work_l7e6s5xjjrez3dcffje2smkysi	7	11	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	7	12	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	13	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	14	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	7	15	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	16	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	17	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	7	19	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	20	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	7	21	;	;	,
work_l7e6s5xjjrez3dcffje2smkysi	7	22	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	23	b	b	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	24	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	25	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	7	26	compare	compare	VB
work_l7e6s5xjjrez3dcffje2smkysi	7	27	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	7	28	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	29	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	30	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	31	between	between	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	32	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	33	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	7	34	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	35	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	7	36	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	7	37	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	7	38	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	39	c	c	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	40	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	7	41	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	7	42	evaluate	evaluate	VB
work_l7e6s5xjjrez3dcffje2smkysi	7	43	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	7	44	response	response	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	45	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	46	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	47	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	7	48	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	49	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	7	50	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	51	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	7	52	post-	post-	VB
work_l7e6s5xjjrez3dcffje2smkysi	7	53	cyclophosphamide	cyclophosphamide	NNP
work_l7e6s5xjjrez3dcffje2smkysi	7	54	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	7	55	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	8	1	METHODS	methods	JJ
work_l7e6s5xjjrez3dcffje2smkysi	8	2	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	8	3	records	record	NNS
work_l7e6s5xjjrez3dcffje2smkysi	8	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	5	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	8	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	7	who	who	WP
work_l7e6s5xjjrez3dcffje2smkysi	8	8	attended	attend	VBD
work_l7e6s5xjjrez3dcffje2smkysi	8	9	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	8	10	Pediatric	Pediatric	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	11	Efficacy	Efficacy	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	12	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	13	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	14	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	15	Children	Children	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	16	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	17	Frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	8	18	Relapsing	Relapsing	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	19	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	8	20	Steroid	Steroid	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	21	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	8	22	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	8	23	Nephrotic	Nephrotic	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	24	Syndrome	Syndrome	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	25	SUDHA	SUDHA	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	26	EKAMBARAM	EKAMBARAM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	27	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	28	VIJAYAKUMAR	VIJAYAKUMAR	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	29	MAHALINGAM	MAHALINGAM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	30	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	31	PRAHLAD	PRAHLAD	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	32	NAGESWARAN	NAGESWARAN	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	33	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	34	AMISH	AMISH	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	35	UDANI	UDANI	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	36	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	37	SANGEETHA	SANGEETHA	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	38	GEMINIGANESAN	GEMINIGANESAN	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	39	AND	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	8	40	SHWETA	shweta	NN
work_l7e6s5xjjrez3dcffje2smkysi	8	41	PRIYADARSHINI	PRIYADARSHINI	NNS
work_l7e6s5xjjrez3dcffje2smkysi	8	42	From	from	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	43	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	8	44	Department	Department	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	45	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	8	46	Pediatric	Pediatric	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	47	Nephrology	Nephrology	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	48	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	49	Mehta	Mehta	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	50	Children	Children	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	51	’s	’s	POS
work_l7e6s5xjjrez3dcffje2smkysi	8	52	Hospital	Hospital	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	53	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	54	Chennai	Chennai	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	55	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	8	56	India	India	NNP
work_l7e6s5xjjrez3dcffje2smkysi	8	57	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	9	1	Correspondence	correspondence	NN
work_l7e6s5xjjrez3dcffje2smkysi	9	2	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	9	3	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	9	4	Dr	Dr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	5	M	M	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	6	Vijayakumar	Vijayakumar	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	7	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	8	Consultant	Consultant	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	9	Pediatric	Pediatric	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	10	Nephrologist	Nephrologist	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	11	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	12	Mehta	Mehta	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	13	Children	Children	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	14	’s	’s	POS
work_l7e6s5xjjrez3dcffje2smkysi	9	15	Hospitals	Hospitals	NNPS
work_l7e6s5xjjrez3dcffje2smkysi	9	16	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	17	No.2(e	no.2(e	ADD
work_l7e6s5xjjrez3dcffje2smkysi	9	18	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	9	19	Mc	Mc	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	20	Nichols	Nichols	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	21	Road	Road	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	22	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	23	3rd	3rd	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	24	Lane	Lane	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	25	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	26	Chetpet	Chetpet	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	27	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	28	Chennai	Chennai	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	29	600	600	CD
work_l7e6s5xjjrez3dcffje2smkysi	9	30	031	031	CD
work_l7e6s5xjjrez3dcffje2smkysi	9	31	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	32	Tamilnadu	Tamilnadu	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	33	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	9	34	India	India	NNP
work_l7e6s5xjjrez3dcffje2smkysi	9	35	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	10	1	doctormvk@gmail.com	doctormvk@gmail.com	ADD
work_l7e6s5xjjrez3dcffje2smkysi	10	2	Received	receive	VBN
work_l7e6s5xjjrez3dcffje2smkysi	10	3	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	10	4	August	August	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	5	05	05	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	10	7	2013	2013	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	8	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	10	9	Initial	Initial	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	10	Review	Review	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	11	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	10	12	August	August	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	13	28	28	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	14	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	10	15	2013	2013	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	16	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	10	17	Accepted	Accepted	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	18	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	10	19	March	March	NNP
work_l7e6s5xjjrez3dcffje2smkysi	10	20	06	06	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	21	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	10	22	2014	2014	CD
work_l7e6s5xjjrez3dcffje2smkysi	10	23	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	11	1	Objectives	objective	NNS
work_l7e6s5xjjrez3dcffje2smkysi	11	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	11	3	To	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	11	4	assess	assess	VB
work_l7e6s5xjjrez3dcffje2smkysi	11	5	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	11	6	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	11	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	11	8	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	11	9	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	11	10	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	11	11	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	11	12	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	11	13	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	11	14	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	11	15	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	11	16	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	11	17	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	11	18	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	11	19	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	11	20	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	12	1	Study	Study	NNP
work_l7e6s5xjjrez3dcffje2smkysi	12	2	Design	Design	NNP
work_l7e6s5xjjrez3dcffje2smkysi	12	3	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	12	4	Retrospective	retrospective	VB
work_l7e6s5xjjrez3dcffje2smkysi	12	5	analysis	analysis	NN
work_l7e6s5xjjrez3dcffje2smkysi	12	6	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	12	7	hospital	hospital	NN
work_l7e6s5xjjrez3dcffje2smkysi	12	8	case	case	NN
work_l7e6s5xjjrez3dcffje2smkysi	12	9	records	record	NNS
work_l7e6s5xjjrez3dcffje2smkysi	12	10	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	13	1	Setting	set	VBG
work_l7e6s5xjjrez3dcffje2smkysi	13	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	13	3	Pediatric	pediatric	JJ
work_l7e6s5xjjrez3dcffje2smkysi	13	4	nephrology	nephrology	NN
work_l7e6s5xjjrez3dcffje2smkysi	13	5	department	department	NN
work_l7e6s5xjjrez3dcffje2smkysi	13	6	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	13	7	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	13	8	tertiary	tertiary	JJ
work_l7e6s5xjjrez3dcffje2smkysi	13	9	referral	referral	JJ
work_l7e6s5xjjrez3dcffje2smkysi	13	10	pediatric	pediatric	JJ
work_l7e6s5xjjrez3dcffje2smkysi	13	11	hospital	hospital	NN
work_l7e6s5xjjrez3dcffje2smkysi	13	12	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	14	1	Participants	participant	NNS
work_l7e6s5xjjrez3dcffje2smkysi	14	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	14	3	62	62	CD
work_l7e6s5xjjrez3dcffje2smkysi	14	4	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	14	5	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	14	6	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	14	7	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	14	8	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	14	9	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	14	10	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	14	11	35	35	CD
work_l7e6s5xjjrez3dcffje2smkysi	14	12	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	14	13	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	14	14	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	14	15	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	14	16	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	14	17	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	14	18	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	14	19	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	15	1	Methods	method	NNS
work_l7e6s5xjjrez3dcffje2smkysi	15	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	15	3	Case	case	NN
work_l7e6s5xjjrez3dcffje2smkysi	15	4	records	record	NNS
work_l7e6s5xjjrez3dcffje2smkysi	15	5	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	15	6	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	15	7	who	who	WP
work_l7e6s5xjjrez3dcffje2smkysi	15	8	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	15	9	diagnosed	diagnose	VBN
work_l7e6s5xjjrez3dcffje2smkysi	15	10	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	15	11	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	15	12	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	15	13	dependant	dependant	JJ
work_l7e6s5xjjrez3dcffje2smkysi	15	14	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	15	15	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	15	16	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	15	17	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	15	18	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	15	19	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	15	20	from	from	IN
work_l7e6s5xjjrez3dcffje2smkysi	15	21	June	June	NNP
work_l7e6s5xjjrez3dcffje2smkysi	15	22	2004	2004	CD
work_l7e6s5xjjrez3dcffje2smkysi	15	23	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	15	24	June	June	NNP
work_l7e6s5xjjrez3dcffje2smkysi	15	25	2011	2011	CD
work_l7e6s5xjjrez3dcffje2smkysi	15	26	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	15	27	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	15	28	reviewed	review	VBN
work_l7e6s5xjjrez3dcffje2smkysi	15	29	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	16	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	16	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	16	3	given	give	VBN
work_l7e6s5xjjrez3dcffje2smkysi	16	4	daily	daily	RB
work_l7e6s5xjjrez3dcffje2smkysi	16	5	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	16	6	2	2	CD
work_l7e6s5xjjrez3dcffje2smkysi	16	7	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	16	8	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	16	9	kg	kg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	16	10	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	16	11	d	d	NNP
work_l7e6s5xjjrez3dcffje2smkysi	16	12	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	16	13	along	along	IN
work_l7e6s5xjjrez3dcffje2smkysi	16	14	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	16	15	tapering	taper	VBG
work_l7e6s5xjjrez3dcffje2smkysi	16	16	doses	dose	NNS
work_l7e6s5xjjrez3dcffje2smkysi	16	17	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	16	18	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	16	19	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	16	20	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	16	21	after	after	IN
work_l7e6s5xjjrez3dcffje2smkysi	16	22	remission	remission	NN
work_l7e6s5xjjrez3dcffje2smkysi	16	23	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	16	24	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	16	25	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	16	26	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	17	1	Results	result	NNS
work_l7e6s5xjjrez3dcffje2smkysi	17	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	17	3	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	17	4	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	17	5	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	17	6	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	17	7	77.3	77.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	17	8	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	17	9	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	17	10	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	17	11	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	17	12	better	well	JJR
work_l7e6s5xjjrez3dcffje2smkysi	17	13	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	17	14	80.6	80.6	CD
work_l7e6s5xjjrez3dcffje2smkysi	17	15	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	17	16	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	17	17	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	17	18	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	17	19	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	17	20	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	17	21	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	17	22	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	17	23	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	18	1	A	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	18	2	total	total	NN
work_l7e6s5xjjrez3dcffje2smkysi	18	3	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	18	4	34	34	CD
work_l7e6s5xjjrez3dcffje2smkysi	18	5	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	18	6	completed	complete	VBN
work_l7e6s5xjjrez3dcffje2smkysi	18	7	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	18	8	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	18	9	follow	follow	NN
work_l7e6s5xjjrez3dcffje2smkysi	18	10	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	18	11	up	up	RP
work_l7e6s5xjjrez3dcffje2smkysi	18	12	post	post	JJ
work_l7e6s5xjjrez3dcffje2smkysi	18	13	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	18	14	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	18	15	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	19	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	19	2	cumulative	cumulative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	19	3	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	19	4	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	5	SD	SD	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	6	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	7	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	19	8	dose	dose	VBD
work_l7e6s5xjjrez3dcffje2smkysi	19	9	1-year	1-year	CD
work_l7e6s5xjjrez3dcffje2smkysi	19	10	before	before	IN
work_l7e6s5xjjrez3dcffje2smkysi	19	11	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	19	12	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	19	13	4109(1154	4109(1154	CD
work_l7e6s5xjjrez3dcffje2smkysi	19	14	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	15	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	16	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	19	17	m2	m2	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	19	19	1-year	1-year	CD
work_l7e6s5xjjrez3dcffje2smkysi	19	20	post	post	NN
work_l7e6s5xjjrez3dcffje2smkysi	19	21	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	19	22	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	19	23	661	661	CD
work_l7e6s5xjjrez3dcffje2smkysi	19	24	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	25	11	11	CD
work_l7e6s5xjjrez3dcffje2smkysi	19	26	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	27	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	28	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	19	29	m2	m2	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	30	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	31	P<0.001	P<0.001	NNP
work_l7e6s5xjjrez3dcffje2smkysi	19	32	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	19	33	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	20	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	20	2	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	20	3	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	20	4	also	also	RB
work_l7e6s5xjjrez3dcffje2smkysi	20	5	less	less	JJR
work_l7e6s5xjjrez3dcffje2smkysi	20	6	during	during	IN
work_l7e6s5xjjrez3dcffje2smkysi	20	7	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	20	8	period	period	NN
work_l7e6s5xjjrez3dcffje2smkysi	20	9	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	20	10	post	post	JJ
work_l7e6s5xjjrez3dcffje2smkysi	20	11	-	-	JJ
work_l7e6s5xjjrez3dcffje2smkysi	20	12	levamisole	levamisole	JJ
work_l7e6s5xjjrez3dcffje2smkysi	20	13	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	20	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	21	1	Conclusion	conclusion	NN
work_l7e6s5xjjrez3dcffje2smkysi	21	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	21	3	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	21	4	is	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	21	5	an	an	DT
work_l7e6s5xjjrez3dcffje2smkysi	21	6	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	21	7	alternative	alternative	NN
work_l7e6s5xjjrez3dcffje2smkysi	21	8	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	21	9	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	21	10	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	21	11	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	21	12	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	21	13	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	21	14	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	21	15	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	21	16	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	21	17	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	21	18	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	22	1	Keywords	keyword	NNS
work_l7e6s5xjjrez3dcffje2smkysi	22	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	22	3	Treatment	Treatment	NNP
work_l7e6s5xjjrez3dcffje2smkysi	22	4	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	22	5	Steroids	Steroids	NNPS
work_l7e6s5xjjrez3dcffje2smkysi	22	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	22	7	Outcome	Outcome	NNP
work_l7e6s5xjjrez3dcffje2smkysi	22	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	22	9	Relapse	Relapse	NNP
work_l7e6s5xjjrez3dcffje2smkysi	22	10	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	22	11	Nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	22	12	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	22	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	23	1	RRRRR	RRRRR	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	2	EEEEE	eeeee	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	3	SSSSS	ssss	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	23	4	EEEEE	eeeee	VBP
work_l7e6s5xjjrez3dcffje2smkysi	23	5	AAAAA	aaaaa	JJ
work_l7e6s5xjjrez3dcffje2smkysi	23	6	RRRRR	rrrrr	JJ
work_l7e6s5xjjrez3dcffje2smkysi	23	7	CCCCC	ccccc	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	8	H	h	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	9	PH	PH	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	10	PH	PH	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	11	PH	PH	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	12	PH	PH	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	13	P	p	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	14	AAAAA	aaaaa	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	15	PPPPP	ppppp	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	16	EEEEE	eeeee	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	17	RRRRR	rrrrr	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	18	INDIAN	indian	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	19	PEDIATRICS	pediatric	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	23	20	371	371	CD
work_l7e6s5xjjrez3dcffje2smkysi	23	21	VOLUME	volume	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	22	51__MAY	51__may	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	23	15	15	CD
work_l7e6s5xjjrez3dcffje2smkysi	23	24	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	23	25	2014	2014	CD
work_l7e6s5xjjrez3dcffje2smkysi	23	26	Nephrology	nephrology	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	27	clinic	clinic	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	28	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	23	29	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	23	30	tertiary	tertiary	JJ
work_l7e6s5xjjrez3dcffje2smkysi	23	31	pediatric	pediatric	JJ
work_l7e6s5xjjrez3dcffje2smkysi	23	32	referral	referral	JJ
work_l7e6s5xjjrez3dcffje2smkysi	23	33	hospital	hospital	NN
work_l7e6s5xjjrez3dcffje2smkysi	23	34	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	23	35	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	23	36	Southern	Southern	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	37	India	India	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	38	between	between	IN
work_l7e6s5xjjrez3dcffje2smkysi	23	39	June	June	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	40	2004	2004	CD
work_l7e6s5xjjrez3dcffje2smkysi	23	41	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	23	42	June	June	NNP
work_l7e6s5xjjrez3dcffje2smkysi	23	43	2011	2011	CD
work_l7e6s5xjjrez3dcffje2smkysi	23	44	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	23	45	analyzed	analyze	VBN
work_l7e6s5xjjrez3dcffje2smkysi	23	46	retrospectively	retrospectively	RB
work_l7e6s5xjjrez3dcffje2smkysi	23	47	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	24	1	Children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	24	2	aged	age	VBD
work_l7e6s5xjjrez3dcffje2smkysi	24	3	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	24	4	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	24	5	18	18	CD
work_l7e6s5xjjrez3dcffje2smkysi	24	6	years	year	NNS
work_l7e6s5xjjrez3dcffje2smkysi	24	7	receiving	receive	VBG
work_l7e6s5xjjrez3dcffje2smkysi	24	8	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	24	9	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	24	10	at	at	RB
work_l7e6s5xjjrez3dcffje2smkysi	24	11	least	least	JJS
work_l7e6s5xjjrez3dcffje2smkysi	24	12	six	six	CD
work_l7e6s5xjjrez3dcffje2smkysi	24	13	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	24	14	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	24	15	treatment	treatment	NN
work_l7e6s5xjjrez3dcffje2smkysi	24	16	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	24	17	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	24	18	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	24	19	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	24	20	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	24	21	included	include	VBN
work_l7e6s5xjjrez3dcffje2smkysi	24	22	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	25	1	Infantile	Infantile	NNP
work_l7e6s5xjjrez3dcffje2smkysi	25	2	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	25	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	25	4	congenital	congenital	JJ
work_l7e6s5xjjrez3dcffje2smkysi	25	5	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	25	6	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	25	7	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	25	8	secondary	secondary	JJ
work_l7e6s5xjjrez3dcffje2smkysi	25	9	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	25	10	systemic	systemic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	25	11	illnesses	illness	NNS
work_l7e6s5xjjrez3dcffje2smkysi	25	12	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	25	13	excluded	exclude	VBN
work_l7e6s5xjjrez3dcffje2smkysi	25	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	26	1	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	26	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	26	3	defined	define	VBN
work_l7e6s5xjjrez3dcffje2smkysi	26	4	when	when	WRB
work_l7e6s5xjjrez3dcffje2smkysi	26	5	there	there	EX
work_l7e6s5xjjrez3dcffje2smkysi	26	6	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	26	7	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	26	8	consecutive	consecutive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	26	9	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	26	10	while	while	IN
work_l7e6s5xjjrez3dcffje2smkysi	26	11	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	26	12	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	26	13	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	26	14	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	26	15	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	26	16	within	within	IN
work_l7e6s5xjjrez3dcffje2smkysi	26	17	14	14	CD
work_l7e6s5xjjrez3dcffje2smkysi	26	18	days	day	NNS
work_l7e6s5xjjrez3dcffje2smkysi	26	19	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	26	20	their	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	26	21	discontinuation	discontinuation	NN
work_l7e6s5xjjrez3dcffje2smkysi	26	22	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	27	1	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	27	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	27	3	defined	define	VBN
work_l7e6s5xjjrez3dcffje2smkysi	27	4	by	by	IN
work_l7e6s5xjjrez3dcffje2smkysi	27	5	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	27	6	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	27	7	more	more	JJR
work_l7e6s5xjjrez3dcffje2smkysi	27	8	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	27	9	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	27	10	six	six	CD
work_l7e6s5xjjrez3dcffje2smkysi	27	11	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	27	12	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	27	13	more	more	JJR
work_l7e6s5xjjrez3dcffje2smkysi	27	14	than	than	IN
work_l7e6s5xjjrez3dcffje2smkysi	27	15	three	three	CD
work_l7e6s5xjjrez3dcffje2smkysi	27	16	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	27	17	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	27	18	any	any	DT
work_l7e6s5xjjrez3dcffje2smkysi	27	19	twelve	twelve	CD
work_l7e6s5xjjrez3dcffje2smkysi	27	20	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	27	21	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	28	1	Relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	28	2	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	28	3	treated	treat	VBN
work_l7e6s5xjjrez3dcffje2smkysi	28	4	according	accord	VBG
work_l7e6s5xjjrez3dcffje2smkysi	28	5	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	28	6	Indian	Indian	NNP
work_l7e6s5xjjrez3dcffje2smkysi	28	7	Pediatric	Pediatric	NNP
work_l7e6s5xjjrez3dcffje2smkysi	28	8	Nephrology	Nephrology	NNP
work_l7e6s5xjjrez3dcffje2smkysi	28	9	Group	Group	NNP
work_l7e6s5xjjrez3dcffje2smkysi	28	10	guidelines	guideline	NNS
work_l7e6s5xjjrez3dcffje2smkysi	28	11	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	28	12	4	4	CD
work_l7e6s5xjjrez3dcffje2smkysi	28	13	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	28	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	29	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	29	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	29	3	started	start	VBN
work_l7e6s5xjjrez3dcffje2smkysi	29	4	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	5	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	29	6	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	29	7	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	29	8	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	29	9	daily	daily	RB
work_l7e6s5xjjrez3dcffje2smkysi	29	10	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	11	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	29	12	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	29	13	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	14	2	2	CD
work_l7e6s5xjjrez3dcffje2smkysi	29	15	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	29	16	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	29	17	kg	kg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	29	18	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	29	19	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	29	20	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	21	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	29	22	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	29	23	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	24	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	29	25	weeks	week	NNS
work_l7e6s5xjjrez3dcffje2smkysi	29	26	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	27	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	29	28	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	29	29	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	29	30	inducing	induce	VBG
work_l7e6s5xjjrez3dcffje2smkysi	29	31	remission	remission	NN
work_l7e6s5xjjrez3dcffje2smkysi	29	32	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	30	1	Prednisolone	prednisolone	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	30	3	given	give	VBN
work_l7e6s5xjjrez3dcffje2smkysi	30	4	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	5	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	30	6	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	8	1.5	1.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	9	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	10	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	30	11	kg	kg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	12	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	30	13	other	other	JJ
work_l7e6s5xjjrez3dcffje2smkysi	30	14	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	15	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	16	4	4	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	17	weeks	week	NNS
work_l7e6s5xjjrez3dcffje2smkysi	30	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	30	19	then	then	RB
work_l7e6s5xjjrez3dcffje2smkysi	30	20	gradually	gradually	RB
work_l7e6s5xjjrez3dcffje2smkysi	30	21	tapered	taper	VBD
work_l7e6s5xjjrez3dcffje2smkysi	30	22	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	23	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	30	24	maintenance	maintenance	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	25	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	26	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	27	0.5	0.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	28	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	29	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	30	30	kg	kg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	31	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	30	32	other	other	JJ
work_l7e6s5xjjrez3dcffje2smkysi	30	33	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	34	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	35	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	36	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	30	37	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	30	38	0.25	0.25	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	39	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	40	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	30	41	kg	kg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	30	42	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	30	43	other	other	JJ
work_l7e6s5xjjrez3dcffje2smkysi	30	44	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	45	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	46	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	47	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	30	48	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	30	49	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	30	50	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	31	1	All	all	DT
work_l7e6s5xjjrez3dcffje2smkysi	31	2	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	31	3	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	31	4	monitored	monitor	VBN
work_l7e6s5xjjrez3dcffje2smkysi	31	5	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	31	6	three	three	CD
work_l7e6s5xjjrez3dcffje2smkysi	31	7	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	31	8	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	31	9	response	response	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	10	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	31	11	side	side	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	12	effects	effect	NNS
work_l7e6s5xjjrez3dcffje2smkysi	31	13	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	31	14	urinalysis	urinalysis	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	15	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	31	16	total	total	JJ
work_l7e6s5xjjrez3dcffje2smkysi	31	17	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	31	18	differential	differential	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	19	blood	blood	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	20	cell	cell	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	21	counts	count	NNS
work_l7e6s5xjjrez3dcffje2smkysi	31	22	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	31	23	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	31	24	liver	liver	NN
work_l7e6s5xjjrez3dcffje2smkysi	31	25	enzymes	enzyme	NNS
work_l7e6s5xjjrez3dcffje2smkysi	31	26	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	31	27	done	do	VBN
work_l7e6s5xjjrez3dcffje2smkysi	31	28	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	32	1	At	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	32	2	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	32	3	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	32	5	one	one	CD
work_l7e6s5xjjrez3dcffje2smkysi	32	6	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	7	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	32	8	serum	serum	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	9	albumin	albumin	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	10	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	32	11	serum	serum	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	12	cholesterol	cholesterol	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	13	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	32	14	urine	urine	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	15	albumin	albumin	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	16	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	32	17	checked	check	VBN
work_l7e6s5xjjrez3dcffje2smkysi	32	18	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	32	19	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	32	20	if	if	IN
work_l7e6s5xjjrez3dcffje2smkysi	32	21	under	under	IN
work_l7e6s5xjjrez3dcffje2smkysi	32	22	remission	remission	NN
work_l7e6s5xjjrez3dcffje2smkysi	32	23	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	32	24	EKAMBARAM	EKAMBARAM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	25	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	32	26	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	27	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	32	28	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	33	1	LEVAMISOLE	LEVAMISOLE	NNP
work_l7e6s5xjjrez3dcffje2smkysi	33	2	IN	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	33	3	NEPHROTIC	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	33	4	SYNDROME	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	33	5	INDIAN	INDIAN	NNP
work_l7e6s5xjjrez3dcffje2smkysi	33	6	PEDIATRICS	PEDIATRICS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	33	7	372	372	CD
work_l7e6s5xjjrez3dcffje2smkysi	33	8	VOLUME	volume	NN
work_l7e6s5xjjrez3dcffje2smkysi	33	9	51__MAY	51__MAY	NNP
work_l7e6s5xjjrez3dcffje2smkysi	33	10	15	15	CD
work_l7e6s5xjjrez3dcffje2smkysi	33	11	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	33	12	2014	2014	CD
work_l7e6s5xjjrez3dcffje2smkysi	33	13	prednisolone	prednisolone	NN
work_l7e6s5xjjrez3dcffje2smkysi	33	14	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	33	15	discontinued	discontinue	VBN
work_l7e6s5xjjrez3dcffje2smkysi	33	16	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	34	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	34	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	34	3	stopped	stop	VBN
work_l7e6s5xjjrez3dcffje2smkysi	34	4	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	34	5	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	34	6	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	34	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	34	8	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	34	9	years	year	NNS
work_l7e6s5xjjrez3dcffje2smkysi	34	10	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	34	11	these	these	DT
work_l7e6s5xjjrez3dcffje2smkysi	34	12	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	34	13	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	34	14	followed	follow	VBN
work_l7e6s5xjjrez3dcffje2smkysi	34	15	up	up	RP
work_l7e6s5xjjrez3dcffje2smkysi	34	16	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	34	17	at	at	RB
work_l7e6s5xjjrez3dcffje2smkysi	34	18	least	least	RBS
work_l7e6s5xjjrez3dcffje2smkysi	34	19	one	one	CD
work_l7e6s5xjjrez3dcffje2smkysi	34	20	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	34	21	following	follow	VBG
work_l7e6s5xjjrez3dcffje2smkysi	34	22	cessation	cessation	NN
work_l7e6s5xjjrez3dcffje2smkysi	34	23	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	34	24	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	34	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	35	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	35	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	35	3	considered	consider	VBN
work_l7e6s5xjjrez3dcffje2smkysi	35	4	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	35	5	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	35	6	if	if	IN
work_l7e6s5xjjrez3dcffje2smkysi	35	7	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	35	8	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	35	9	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	35	10	able	able	JJ
work_l7e6s5xjjrez3dcffje2smkysi	35	11	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	35	12	maintain	maintain	VB
work_l7e6s5xjjrez3dcffje2smkysi	35	13	remission	remission	NN
work_l7e6s5xjjrez3dcffje2smkysi	35	14	when	when	WRB
work_l7e6s5xjjrez3dcffje2smkysi	35	15	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	35	16	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	35	17	tapered	taper	VBN
work_l7e6s5xjjrez3dcffje2smkysi	35	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	35	19	stopped	stop	VBN
work_l7e6s5xjjrez3dcffje2smkysi	35	20	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	36	1	It	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	36	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	36	3	considered	consider	VBN
work_l7e6s5xjjrez3dcffje2smkysi	36	4	ineffective	ineffective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	36	5	if	if	IN
work_l7e6s5xjjrez3dcffje2smkysi	36	6	child	child	NN
work_l7e6s5xjjrez3dcffje2smkysi	36	7	developed	develop	VBD
work_l7e6s5xjjrez3dcffje2smkysi	36	8	two	two	CD
work_l7e6s5xjjrez3dcffje2smkysi	36	9	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	36	10	more	more	JJR
work_l7e6s5xjjrez3dcffje2smkysi	36	11	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	36	12	while	while	IN
work_l7e6s5xjjrez3dcffje2smkysi	36	13	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	36	14	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	36	15	other	other	JJ
work_l7e6s5xjjrez3dcffje2smkysi	36	16	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	36	17	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	36	18	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	36	19	when	when	WRB
work_l7e6s5xjjrez3dcffje2smkysi	36	20	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	36	21	could	could	MD
work_l7e6s5xjjrez3dcffje2smkysi	36	22	not	not	RB
work_l7e6s5xjjrez3dcffje2smkysi	36	23	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	36	24	withdrawn	withdraw	VBN
work_l7e6s5xjjrez3dcffje2smkysi	36	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	37	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	37	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	37	3	stopped	stop	VBN
work_l7e6s5xjjrez3dcffje2smkysi	37	4	when	when	WRB
work_l7e6s5xjjrez3dcffje2smkysi	37	5	it	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	37	6	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	37	7	considered	consider	VBN
work_l7e6s5xjjrez3dcffje2smkysi	37	8	ineffective	ineffective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	37	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	38	1	Children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	38	2	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	38	3	post	post	JJ
work_l7e6s5xjjrez3dcffje2smkysi	38	4	-	-	JJ
work_l7e6s5xjjrez3dcffje2smkysi	38	5	immunosuppressive	immunosuppressive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	38	6	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	38	7	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	38	8	cyclophosphamide	cyclophosphamide	NNP
work_l7e6s5xjjrez3dcffje2smkysi	38	9	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	38	10	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	38	11	presenting	present	VBG
work_l7e6s5xjjrez3dcffje2smkysi	38	12	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	38	13	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	38	14	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	38	15	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	38	16	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	38	17	included	include	VBN
work_l7e6s5xjjrez3dcffje2smkysi	38	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	38	19	their	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	38	20	response	response	NN
work_l7e6s5xjjrez3dcffje2smkysi	38	21	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	38	22	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	38	23	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	38	24	analyzed	analyze	VBN
work_l7e6s5xjjrez3dcffje2smkysi	38	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	39	1	Statistical	statistical	JJ
work_l7e6s5xjjrez3dcffje2smkysi	39	2	analyses	analysis	NNS
work_l7e6s5xjjrez3dcffje2smkysi	39	3	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	39	4	done	do	VBN
work_l7e6s5xjjrez3dcffje2smkysi	39	5	using	use	VBG
work_l7e6s5xjjrez3dcffje2smkysi	39	6	Repeated	Repeated	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	7	measures	measure	NNS
work_l7e6s5xjjrez3dcffje2smkysi	39	8	ANOVA	ANOVA	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	9	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	39	10	F	F	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	11	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	39	12	test	test	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	13	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	39	14	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	39	15	Chi	Chi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	16	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	39	17	Squared	Squared	NNP
work_l7e6s5xjjrez3dcffje2smkysi	39	18	test	test	NN
work_l7e6s5xjjrez3dcffje2smkysi	39	19	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	40	1	P	p	NN
work_l7e6s5xjjrez3dcffje2smkysi	40	2	<	<	XX
work_l7e6s5xjjrez3dcffje2smkysi	40	3	0.05	0.05	XX
work_l7e6s5xjjrez3dcffje2smkysi	40	4	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	40	5	taken	take	VBN
work_l7e6s5xjjrez3dcffje2smkysi	40	6	as	as	RB
work_l7e6s5xjjrez3dcffje2smkysi	40	7	significant	significant	JJ
work_l7e6s5xjjrez3dcffje2smkysi	40	8	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	41	1	RESULTS	RESULTS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	41	2	A	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	41	3	total	total	NN
work_l7e6s5xjjrez3dcffje2smkysi	41	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	41	5	97	97	CD
work_l7e6s5xjjrez3dcffje2smkysi	41	6	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	41	7	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	41	8	53	53	CD
work_l7e6s5xjjrez3dcffje2smkysi	41	9	boys	boy	NNS
work_l7e6s5xjjrez3dcffje2smkysi	41	10	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	41	11	completed	complete	VBD
work_l7e6s5xjjrez3dcffje2smkysi	41	12	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	41	13	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	41	14	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	41	15	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	41	16	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	41	17	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	41	18	62	62	CD
work_l7e6s5xjjrez3dcffje2smkysi	41	19	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	41	20	64	64	CD
work_l7e6s5xjjrez3dcffje2smkysi	41	21	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	41	22	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	41	23	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	41	24	these	these	DT
work_l7e6s5xjjrez3dcffje2smkysi	41	25	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	41	26	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	41	27	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	42	1	None	none	NN
work_l7e6s5xjjrez3dcffje2smkysi	42	2	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	42	3	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	42	4	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	42	5	had	have	VBD
work_l7e6s5xjjrez3dcffje2smkysi	42	6	renal	renal	JJ
work_l7e6s5xjjrez3dcffje2smkysi	42	7	failure	failure	NN
work_l7e6s5xjjrez3dcffje2smkysi	42	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	42	9	hypertension	hypertension	NN
work_l7e6s5xjjrez3dcffje2smkysi	42	10	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	42	11	gross	gross	JJ
work_l7e6s5xjjrez3dcffje2smkysi	42	12	hematuria	hematuria	NN
work_l7e6s5xjjrez3dcffje2smkysi	42	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	43	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	43	2	baseline	baseline	JJ
work_l7e6s5xjjrez3dcffje2smkysi	43	3	characteristics	characteristic	NNS
work_l7e6s5xjjrez3dcffje2smkysi	43	4	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	43	5	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	43	6	start	start	NN
work_l7e6s5xjjrez3dcffje2smkysi	43	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	43	8	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	43	9	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	43	10	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	43	11	shown	show	VBN
work_l7e6s5xjjrez3dcffje2smkysi	43	12	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	43	13	Table	table	NN
work_l7e6s5xjjrez3dcffje2smkysi	43	14	I.	i.	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	44	2	duration	duration	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	3	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	44	4	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	5	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	6	ranged	range	VBD
work_l7e6s5xjjrez3dcffje2smkysi	44	7	from	from	IN
work_l7e6s5xjjrez3dcffje2smkysi	44	8	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	44	9	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	44	10	24	24	CD
work_l7e6s5xjjrez3dcffje2smkysi	44	11	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	44	12	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	44	13	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	44	14	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	15	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	44	16	SD	sd	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	17	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	44	18	duration	duration	NN
work_l7e6s5xjjrez3dcffje2smkysi	44	19	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	44	20	18.7	18.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	44	21	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	44	22	6.4	6.4	CD
work_l7e6s5xjjrez3dcffje2smkysi	44	23	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	44	24	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	44	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	45	1	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	45	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	45	3	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	45	4	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	45	5	77.3	77.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	45	6	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	45	7	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	45	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	45	9	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	45	10	stopped	stop	VBN
work_l7e6s5xjjrez3dcffje2smkysi	45	11	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	45	12	15	15	CD
work_l7e6s5xjjrez3dcffje2smkysi	45	13	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	45	14	15.5	15.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	45	15	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	45	16	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	45	17	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	45	18	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	45	19	it	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	45	20	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	45	21	ineffective	ineffective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	45	22	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	45	23	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	45	24	7	7	CD
work_l7e6s5xjjrez3dcffje2smkysi	45	25	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	45	26	7.2	7.2	CD
work_l7e6s5xjjrez3dcffje2smkysi	45	27	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	45	28	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	45	29	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	45	30	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	45	31	lost	lose	VBN
work_l7e6s5xjjrez3dcffje2smkysi	45	32	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	45	33	follow	follow	VB
work_l7e6s5xjjrez3dcffje2smkysi	45	34	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	45	35	up	up	NN
work_l7e6s5xjjrez3dcffje2smkysi	45	36	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	46	1	Frequent	frequent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	46	2	relapsers	relapser	NNS
work_l7e6s5xjjrez3dcffje2smkysi	46	3	showed	show	VBD
work_l7e6s5xjjrez3dcffje2smkysi	46	4	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	46	5	better	well	JJR
work_l7e6s5xjjrez3dcffje2smkysi	46	6	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	46	7	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	46	8	levamisole	levamisole	VB
work_l7e6s5xjjrez3dcffje2smkysi	46	9	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	46	10	comparison	comparison	NN
work_l7e6s5xjjrez3dcffje2smkysi	46	11	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	46	12	steroid	steroid	VB
work_l7e6s5xjjrez3dcffje2smkysi	46	13	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	46	14	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	46	15	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	46	16	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	46	17	80.6	80.6	CD
work_l7e6s5xjjrez3dcffje2smkysi	46	18	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	46	19	vs.	vs.	NN
work_l7e6s5xjjrez3dcffje2smkysi	46	20	71.4	71.4	CD
work_l7e6s5xjjrez3dcffje2smkysi	46	21	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	46	22	;	;	,
work_l7e6s5xjjrez3dcffje2smkysi	46	23	P=0.001	P=0.001	NNP
work_l7e6s5xjjrez3dcffje2smkysi	46	24	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	46	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	47	1	Prednisolone	prednisolone	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	2	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	47	3	tapered	taper	VBN
work_l7e6s5xjjrez3dcffje2smkysi	47	4	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	47	5	0.5	0.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	47	6	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	47	7	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	47	8	kg	kg	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	9	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	47	10	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	11	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	47	12	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	47	13	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	14	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	47	15	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	47	16	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	47	17	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	47	18	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	47	19	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	20	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	47	21	SD	sd	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	22	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	47	23	duration	duration	NN
work_l7e6s5xjjrez3dcffje2smkysi	47	24	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	47	25	5	5	CD
work_l7e6s5xjjrez3dcffje2smkysi	47	26	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	47	27	1.1	1.1	CD
work_l7e6s5xjjrez3dcffje2smkysi	47	28	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	47	29	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	47	30	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	48	1	Sixty	sixty	CD
work_l7e6s5xjjrez3dcffje2smkysi	48	2	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	48	3	five	five	CD
work_l7e6s5xjjrez3dcffje2smkysi	48	4	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	48	5	completed	complete	VBD
work_l7e6s5xjjrez3dcffje2smkysi	48	6	one	one	CD
work_l7e6s5xjjrez3dcffje2smkysi	48	7	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	8	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	48	9	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	10	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	48	11	prednisolone	prednisolone	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	12	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	48	13	stopped	stop	VBN
work_l7e6s5xjjrez3dcffje2smkysi	48	14	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	48	15	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	48	16	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	17	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	48	18	SD	sd	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	19	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	48	20	duration	duration	NN
work_l7e6s5xjjrez3dcffje2smkysi	48	21	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	48	22	11.84	11.84	CD
work_l7e6s5xjjrez3dcffje2smkysi	48	23	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	48	24	1.3	1.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	48	25	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	48	26	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	48	27	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	49	1	Mean	Mean	NNP
work_l7e6s5xjjrez3dcffje2smkysi	49	2	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	3	SD	SD	NNP
work_l7e6s5xjjrez3dcffje2smkysi	49	4	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	5	serum	serum	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	6	albumin	albumin	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	7	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	49	8	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	49	9	start	start	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	10	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	49	11	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	12	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	49	13	2.32	2.32	CD
work_l7e6s5xjjrez3dcffje2smkysi	49	14	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	15	0.5	0.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	49	16	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	17	g	g	NNP
work_l7e6s5xjjrez3dcffje2smkysi	49	18	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	49	19	dL	dL	NNP
work_l7e6s5xjjrez3dcffje2smkysi	49	20	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	49	21	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	49	22	completion	completion	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	23	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	49	24	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	49	25	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	49	26	4.12	4.12	CD
work_l7e6s5xjjrez3dcffje2smkysi	49	27	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	28	0.3	0.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	49	29	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	49	30	g	g	NNP
work_l7e6s5xjjrez3dcffje2smkysi	49	31	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	49	32	dL.	dL.	NNP
work_l7e6s5xjjrez3dcffje2smkysi	50	1	At	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	50	2	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	50	3	end	end	NN
work_l7e6s5xjjrez3dcffje2smkysi	50	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	50	5	24	24	CD
work_l7e6s5xjjrez3dcffje2smkysi	50	6	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	50	7	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	50	8	40	40	CD
work_l7e6s5xjjrez3dcffje2smkysi	50	9	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	50	10	completed	complete	VBN
work_l7e6s5xjjrez3dcffje2smkysi	50	11	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	50	12	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	50	13	these	these	DT
work_l7e6s5xjjrez3dcffje2smkysi	50	14	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	50	15	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	50	16	kept	keep	VBN
work_l7e6s5xjjrez3dcffje2smkysi	50	17	under	under	IN
work_l7e6s5xjjrez3dcffje2smkysi	50	18	surveillance	surveillance	NN
work_l7e6s5xjjrez3dcffje2smkysi	50	19	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	50	20	at	at	RB
work_l7e6s5xjjrez3dcffje2smkysi	50	21	least	least	JJS
work_l7e6s5xjjrez3dcffje2smkysi	50	22	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	50	23	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	50	24	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	51	1	A	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	51	2	total	total	NN
work_l7e6s5xjjrez3dcffje2smkysi	51	3	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	51	4	34	34	CD
work_l7e6s5xjjrez3dcffje2smkysi	51	5	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	51	6	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	51	7	followed	follow	VBN
work_l7e6s5xjjrez3dcffje2smkysi	51	8	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	51	9	up	up	NN
work_l7e6s5xjjrez3dcffje2smkysi	51	10	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	51	11	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	51	12	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	51	13	post	post	NN
work_l7e6s5xjjrez3dcffje2smkysi	51	14	-	-	JJ
work_l7e6s5xjjrez3dcffje2smkysi	51	15	therapy	therapy	JJ
work_l7e6s5xjjrez3dcffje2smkysi	51	16	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	51	17	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	51	18	cumulative	cumulative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	51	19	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	51	20	dose	dose	VBP
work_l7e6s5xjjrez3dcffje2smkysi	51	21	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	51	22	relapse	relapse	VB
work_l7e6s5xjjrez3dcffje2smkysi	51	23	rates	rate	NNS
work_l7e6s5xjjrez3dcffje2smkysi	51	24	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	51	25	shown	show	VBN
work_l7e6s5xjjrez3dcffje2smkysi	51	26	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	51	27	Table	Table	NNP
work_l7e6s5xjjrez3dcffje2smkysi	51	28	II	II	NNP
work_l7e6s5xjjrez3dcffje2smkysi	51	29	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	52	1	The	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	52	2	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	52	3	dose	dose	VBP
work_l7e6s5xjjrez3dcffje2smkysi	52	4	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	52	5	relapse	relapse	VB
work_l7e6s5xjjrez3dcffje2smkysi	52	6	rates	rate	NNS
work_l7e6s5xjjrez3dcffje2smkysi	52	7	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	52	8	significantly	significantly	RB
work_l7e6s5xjjrez3dcffje2smkysi	52	9	less	less	JJR
work_l7e6s5xjjrez3dcffje2smkysi	52	10	after	after	IN
work_l7e6s5xjjrez3dcffje2smkysi	52	11	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	52	12	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	52	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	53	1	Relapse	relapse	VB
work_l7e6s5xjjrez3dcffje2smkysi	53	2	free	free	JJ
work_l7e6s5xjjrez3dcffje2smkysi	53	3	period	period	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	4	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	53	5	observed	observe	VBN
work_l7e6s5xjjrez3dcffje2smkysi	53	6	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	53	7	25	25	CD
work_l7e6s5xjjrez3dcffje2smkysi	53	8	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	53	9	73.5	73.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	53	10	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	11	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	53	12	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	53	13	during	during	IN
work_l7e6s5xjjrez3dcffje2smkysi	53	14	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	15	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	53	16	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	53	17	22	22	CD
work_l7e6s5xjjrez3dcffje2smkysi	53	18	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	53	19	64.7	64.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	53	20	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	21	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	53	22	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	53	23	during	during	IN
work_l7e6s5xjjrez3dcffje2smkysi	53	24	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	53	25	one	one	CD
work_l7e6s5xjjrez3dcffje2smkysi	53	26	year	year	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	27	period	period	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	28	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	53	29	post	post	JJ
work_l7e6s5xjjrez3dcffje2smkysi	53	30	-	-	JJ
work_l7e6s5xjjrez3dcffje2smkysi	53	31	levamisole	levamisole	JJ
work_l7e6s5xjjrez3dcffje2smkysi	53	32	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	53	33	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	54	1	Before	before	IN
work_l7e6s5xjjrez3dcffje2smkysi	54	2	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	54	3	administration	administration	NN
work_l7e6s5xjjrez3dcffje2smkysi	54	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	54	5	levamisole	levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	54	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	54	7	7	7	CD
work_l7e6s5xjjrez3dcffje2smkysi	54	8	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	54	9	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	54	10	had	have	VBD
work_l7e6s5xjjrez3dcffje2smkysi	54	11	received	receive	VBN
work_l7e6s5xjjrez3dcffje2smkysi	54	12	cyclophosphamide	cyclophosphamide	NN
work_l7e6s5xjjrez3dcffje2smkysi	54	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	55	1	Renal	renal	JJ
work_l7e6s5xjjrez3dcffje2smkysi	55	2	biopsy	biopsy	NN
work_l7e6s5xjjrez3dcffje2smkysi	55	3	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	55	4	performed	perform	VBN
work_l7e6s5xjjrez3dcffje2smkysi	55	5	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	55	6	all	all	PDT
work_l7e6s5xjjrez3dcffje2smkysi	55	7	these	these	DT
work_l7e6s5xjjrez3dcffje2smkysi	55	8	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	55	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	56	1	Four	four	CD
work_l7e6s5xjjrez3dcffje2smkysi	56	2	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	56	3	had	have	VBD
work_l7e6s5xjjrez3dcffje2smkysi	56	4	minimal	minimal	JJ
work_l7e6s5xjjrez3dcffje2smkysi	56	5	change	change	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	6	disease	disease	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	7	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	56	8	3	3	CD
work_l7e6s5xjjrez3dcffje2smkysi	56	9	had	have	VBD
work_l7e6s5xjjrez3dcffje2smkysi	56	10	diffuse	diffuse	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	11	mesangial	mesangial	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	12	proliferation	proliferation	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	13	by	by	IN
work_l7e6s5xjjrez3dcffje2smkysi	56	14	histopathology	histopathology	NN
work_l7e6s5xjjrez3dcffje2smkysi	56	15	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	57	1	Levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	57	2	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	57	3	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	57	4	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	57	5	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	57	6	5	5	CD
work_l7e6s5xjjrez3dcffje2smkysi	57	7	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	57	8	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	58	1	DISCUSSION	DISCUSSION	NNP
work_l7e6s5xjjrez3dcffje2smkysi	58	2	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	3	this	this	DT
work_l7e6s5xjjrez3dcffje2smkysi	58	4	retrospective	retrospective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	58	5	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	58	6	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	7	97	97	CD
work_l7e6s5xjjrez3dcffje2smkysi	58	8	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	58	9	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	10	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	58	11	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	58	12	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	58	13	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	58	14	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	58	15	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	58	16	found	find	VBN
work_l7e6s5xjjrez3dcffje2smkysi	58	17	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	58	18	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	58	19	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	58	20	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	21	majority	majority	NN
work_l7e6s5xjjrez3dcffje2smkysi	58	22	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	58	23	77.3	77.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	58	24	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	58	25	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	58	26	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	58	27	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	28	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	58	29	better	well	JJR
work_l7e6s5xjjrez3dcffje2smkysi	58	30	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	58	31	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	32	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	58	33	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	34	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	58	35	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	36	compared	compare	VBN
work_l7e6s5xjjrez3dcffje2smkysi	58	37	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	38	those	those	DT
work_l7e6s5xjjrez3dcffje2smkysi	58	39	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	58	40	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	58	41	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	59	1	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	59	2	our	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	59	3	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	4	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	59	5	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	6	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	59	7	administered	administer	VBN
work_l7e6s5xjjrez3dcffje2smkysi	59	8	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	59	9	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	59	10	dosing	dosing	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	11	schedule	schedule	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	12	based	base	VBN
work_l7e6s5xjjrez3dcffje2smkysi	59	13	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	59	14	personal	personal	JJ
work_l7e6s5xjjrez3dcffje2smkysi	59	15	experience	experience	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	16	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	59	17	most	most	JJS
work_l7e6s5xjjrez3dcffje2smkysi	59	18	guidelines	guideline	NNS
work_l7e6s5xjjrez3dcffje2smkysi	59	19	suggest	suggest	VBP
work_l7e6s5xjjrez3dcffje2smkysi	59	20	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	59	21	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	22	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	23	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	59	24	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	59	25	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	59	26	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	60	1	Fu	Fu	NNP
work_l7e6s5xjjrez3dcffje2smkysi	60	2	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	60	3	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	60	4	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	60	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	61	1	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	61	2	5	5	CD
work_l7e6s5xjjrez3dcffje2smkysi	61	3	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	61	4	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	61	5	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	6	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	61	7	comparative	comparative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	8	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	9	between	between	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	10	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	11	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	61	12	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	13	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	14	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	15	usage	usage	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	16	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	17	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	61	18	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	19	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	61	20	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	61	21	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	61	22	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	61	23	reported	report	VBD
work_l7e6s5xjjrez3dcffje2smkysi	61	24	that	that	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	25	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	26	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	27	usage	usage	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	28	can	can	MD
work_l7e6s5xjjrez3dcffje2smkysi	61	29	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	61	30	considered	consider	VBN
work_l7e6s5xjjrez3dcffje2smkysi	61	31	when	when	WRB
work_l7e6s5xjjrez3dcffje2smkysi	61	32	response	response	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	33	to	to	IN
work_l7e6s5xjjrez3dcffje2smkysi	61	34	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	35	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	36	usage	usage	NN
work_l7e6s5xjjrez3dcffje2smkysi	61	37	is	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	61	38	unsatisfactory	unsatisfactory	JJ
work_l7e6s5xjjrez3dcffje2smkysi	61	39	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	62	1	We	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	62	2	did	do	VBD
work_l7e6s5xjjrez3dcffje2smkysi	62	3	not	not	RB
work_l7e6s5xjjrez3dcffje2smkysi	62	4	have	have	VB
work_l7e6s5xjjrez3dcffje2smkysi	62	5	any	any	DT
work_l7e6s5xjjrez3dcffje2smkysi	62	6	comparison	comparison	NN
work_l7e6s5xjjrez3dcffje2smkysi	62	7	group	group	NN
work_l7e6s5xjjrez3dcffje2smkysi	62	8	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	62	9	this	this	DT
work_l7e6s5xjjrez3dcffje2smkysi	62	10	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	62	11	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	62	12	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	62	13	retrospective	retrospective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	62	14	analysis	analysis	NN
work_l7e6s5xjjrez3dcffje2smkysi	62	15	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	63	1	Madani	Madani	NNP
work_l7e6s5xjjrez3dcffje2smkysi	63	2	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	63	3	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	63	4	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	63	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	64	1	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	64	2	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	64	3	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	64	4	evaluated	evaluate	VBD
work_l7e6s5xjjrez3dcffje2smkysi	64	5	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	64	6	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	64	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	64	8	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	64	9	among	among	IN
work_l7e6s5xjjrez3dcffje2smkysi	64	10	304	304	CD
work_l7e6s5xjjrez3dcffje2smkysi	64	11	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	64	12	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	64	13	demonstrated	demonstrate	VBD
work_l7e6s5xjjrez3dcffje2smkysi	64	14	that	that	IN
work_l7e6s5xjjrez3dcffje2smkysi	64	15	it	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	64	16	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	64	17	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	64	18	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	64	19	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	64	20	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	64	21	both	both	DT
work_l7e6s5xjjrez3dcffje2smkysi	64	22	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	64	23	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	64	24	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	64	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	65	1	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	65	2	their	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	65	3	study	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	65	4	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	65	5	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	65	6	relapse	relapse	NN
work_l7e6s5xjjrez3dcffje2smkysi	65	7	rates	rate	NNS
work_l7e6s5xjjrez3dcffje2smkysi	65	8	reduced	reduce	VBN
work_l7e6s5xjjrez3dcffje2smkysi	65	9	by	by	IN
work_l7e6s5xjjrez3dcffje2smkysi	65	10	about	about	RB
work_l7e6s5xjjrez3dcffje2smkysi	65	11	one	one	CD
work_l7e6s5xjjrez3dcffje2smkysi	65	12	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	65	13	half	half	NN
work_l7e6s5xjjrez3dcffje2smkysi	65	14	after	after	IN
work_l7e6s5xjjrez3dcffje2smkysi	65	15	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	65	16	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	65	17	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	66	1	Alsaran	Alsaran	NNP
work_l7e6s5xjjrez3dcffje2smkysi	66	2	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	66	3	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	66	4	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	66	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	67	1	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	67	2	7	7	CD
work_l7e6s5xjjrez3dcffje2smkysi	67	3	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	67	4	documented	document	VBN
work_l7e6s5xjjrez3dcffje2smkysi	67	5	response	response	NN
work_l7e6s5xjjrez3dcffje2smkysi	67	6	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	67	7	90.6	90.6	CD
work_l7e6s5xjjrez3dcffje2smkysi	67	8	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	67	9	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	67	10	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	67	11	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	67	12	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	67	13	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	67	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	68	1	Sumegi	Sumegi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	68	2	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	68	3	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	68	4	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	68	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	69	1	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	69	2	8	8	CD
work_l7e6s5xjjrez3dcffje2smkysi	69	3	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	69	4	followed	follow	VBD
work_l7e6s5xjjrez3dcffje2smkysi	69	5	34	34	CD
work_l7e6s5xjjrez3dcffje2smkysi	69	6	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	69	7	for	for	IN
work_l7e6s5xjjrez3dcffje2smkysi	69	8	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	69	9	duration	duration	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	10	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	69	11	5–36	5–36	CD
work_l7e6s5xjjrez3dcffje2smkysi	69	12	months	month	NNS
work_l7e6s5xjjrez3dcffje2smkysi	69	13	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	69	14	documented	document	VBD
work_l7e6s5xjjrez3dcffje2smkysi	69	15	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	69	16	reduction	reduction	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	17	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	69	18	relapse	relapse	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	19	rate	rate	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	20	after	after	IN
work_l7e6s5xjjrez3dcffje2smkysi	69	21	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	22	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	69	23	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	70	1	Our	-PRON-	PRP$
work_l7e6s5xjjrez3dcffje2smkysi	70	2	results	result	NNS
work_l7e6s5xjjrez3dcffje2smkysi	70	3	are	be	VBP
work_l7e6s5xjjrez3dcffje2smkysi	70	4	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	70	5	concordance	concordance	NN
work_l7e6s5xjjrez3dcffje2smkysi	70	6	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	70	7	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	70	8	above	above	JJ
work_l7e6s5xjjrez3dcffje2smkysi	70	9	studies	study	NNS
work_l7e6s5xjjrez3dcffje2smkysi	70	10	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	71	1	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	71	2	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	71	3	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	71	4	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	71	5	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	71	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	71	7	we	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	71	8	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	71	9	able	able	JJ
work_l7e6s5xjjrez3dcffje2smkysi	71	10	to	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	71	11	taper	taper	VB
work_l7e6s5xjjrez3dcffje2smkysi	71	12	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	71	13	stop	stop	VB
work_l7e6s5xjjrez3dcffje2smkysi	71	14	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	71	15	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	71	16	majority	majority	NN
work_l7e6s5xjjrez3dcffje2smkysi	71	17	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	71	18	patients	patient	NNS
work_l7e6s5xjjrez3dcffje2smkysi	71	19	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	72	1	Bagga	Bagga	NNP
work_l7e6s5xjjrez3dcffje2smkysi	72	2	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	72	3	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	72	4	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	72	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	73	1	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	73	2	9	9	CD
work_l7e6s5xjjrez3dcffje2smkysi	73	3	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	73	4	also	also	RB
work_l7e6s5xjjrez3dcffje2smkysi	73	5	showed	show	VBD
work_l7e6s5xjjrez3dcffje2smkysi	73	6	that	that	IN
work_l7e6s5xjjrez3dcffje2smkysi	73	7	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	73	8	was	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	73	9	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	73	10	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	73	11	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	73	12	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	73	13	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	73	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	74	1	In	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	74	2	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	74	3	meta	meta	JJ
work_l7e6s5xjjrez3dcffje2smkysi	74	4	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	74	5	analysis	analysis	NN
work_l7e6s5xjjrez3dcffje2smkysi	74	6	TABLE	table	NN
work_l7e6s5xjjrez3dcffje2smkysi	74	7	II	ii	CD
work_l7e6s5xjjrez3dcffje2smkysi	74	8	CUMULATIVE	cumulative	NN
work_l7e6s5xjjrez3dcffje2smkysi	74	9	STEROIDS	steroids	NN
work_l7e6s5xjjrez3dcffje2smkysi	74	10	AND	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	74	11	RELAPSE	relapse	VBP
work_l7e6s5xjjrez3dcffje2smkysi	74	12	RATES	rate	NNS
work_l7e6s5xjjrez3dcffje2smkysi	74	13	IN	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	74	14	CHILDREN	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	74	15	WITH	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	74	16	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	74	17	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	74	18	SDNS	sdns	NN
work_l7e6s5xjjrez3dcffje2smkysi	74	19	Duration	Duration	NNP
work_l7e6s5xjjrez3dcffje2smkysi	74	20	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	74	21	Dose	Dose	NNP
work_l7e6s5xjjrez3dcffje2smkysi	74	22	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	74	23	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	74	24	No	no	UH
work_l7e6s5xjjrez3dcffje2smkysi	74	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	75	1	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	75	2	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	75	3	follow	follow	VBP
work_l7e6s5xjjrez3dcffje2smkysi	75	4	up	up	RP
work_l7e6s5xjjrez3dcffje2smkysi	75	5	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	6	mg	mg	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	7	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	75	8	m2)mean	m2)mean	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	9	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	10	SD	sd	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	11	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	12	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	13	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	14	SD	SD	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	15	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	16	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	17	y	y	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	18	before	before	IN
work_l7e6s5xjjrez3dcffje2smkysi	75	19	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	20	4109.29	4109.29	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	21	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	22	1154	1154	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	23	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	24	2.41	2.41	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	25	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	26	0.5	0.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	27	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	28	During	during	IN
work_l7e6s5xjjrez3dcffje2smkysi	75	29	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	30	2491.8	2491.8	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	31	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	32	694	694	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	33	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	34	1.3	1.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	35	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	36	0.7	0.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	37	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	38	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	39	y	y	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	40	after	after	IN
work_l7e6s5xjjrez3dcffje2smkysi	75	41	levamisole	levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	42	660.7	660.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	43	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	44	10.7	10.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	45	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	46	0.48	0.48	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	47	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	48	0.8	0.8	CD
work_l7e6s5xjjrez3dcffje2smkysi	75	49	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	75	50	TABLE	TABLE	NNS
work_l7e6s5xjjrez3dcffje2smkysi	75	51	I	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	75	52	BASELINE	baseline	VBP
work_l7e6s5xjjrez3dcffje2smkysi	75	53	CHARACTERISTICS	characteristic	NNS
work_l7e6s5xjjrez3dcffje2smkysi	75	54	OF	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	75	55	THE	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	75	56	STUDY	STUDY	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	57	POPULATION	POPULATION	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	58	Characteristic	Characteristic	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	59	SDNS	sdn	NNS
work_l7e6s5xjjrez3dcffje2smkysi	75	60	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	75	61	No	no	NN
work_l7e6s5xjjrez3dcffje2smkysi	75	62	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	76	1	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	2	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	3	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	4	35	35	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	5	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	6	36.1	36.1	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	7	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	8	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	9	62	62	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	10	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	11	63.9	63.9	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	12	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	13	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	14	Male	male	JJ
work_l7e6s5xjjrez3dcffje2smkysi	76	15	gender	gender	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	16	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	76	17	n	n	CC
work_l7e6s5xjjrez3dcffje2smkysi	76	18	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	19	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	20	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	21	18	18	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	22	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	23	51.4	51.4	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	24	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	25	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	26	35	35	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	27	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	28	56.5	56.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	29	%	%	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	30	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	31	Age	age	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	32	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	76	33	diagnosis	diagnosis	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	34	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	76	35	y	y	NNP
work_l7e6s5xjjrez3dcffje2smkysi	76	36	2.5	2.5	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	37	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	38	1.1	1.1	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	39	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	40	3.1	3.1	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	41	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	42	1.8	1.8	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	43	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	44	Age	age	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	45	at	at	IN
work_l7e6s5xjjrez3dcffje2smkysi	76	46	beginning	beginning	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	47	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	76	48	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	49	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	76	50	y	y	NNP
work_l7e6s5xjjrez3dcffje2smkysi	76	51	3.9	3.9	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	52	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	53	1.7	1.7	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	54	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	55	4.8	4.8	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	56	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	57	2.3	2.3	CD
work_l7e6s5xjjrez3dcffje2smkysi	76	58	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	59	SDNS	sdns	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	60	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	76	61	–	–	:
work_l7e6s5xjjrez3dcffje2smkysi	76	62	Steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	63	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	76	64	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	76	65	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	76	66	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	67	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	76	68	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	76	69	–	–	:
work_l7e6s5xjjrez3dcffje2smkysi	76	70	Frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	76	71	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	76	72	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	76	73	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	74	;	;	:
work_l7e6s5xjjrez3dcffje2smkysi	76	75	*	*	NFP
work_l7e6s5xjjrez3dcffje2smkysi	76	76	Values	value	NNS
work_l7e6s5xjjrez3dcffje2smkysi	76	77	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	76	78	mean	mean	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	79	(	(	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	80	SD	sd	NN
work_l7e6s5xjjrez3dcffje2smkysi	76	81	)	)	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	76	82	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	77	1	INDIAN	INDIAN	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	2	PEDIATRICS	PEDIATRICS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	3	373	373	CD
work_l7e6s5xjjrez3dcffje2smkysi	77	4	VOLUME	volume	NN
work_l7e6s5xjjrez3dcffje2smkysi	77	5	51__MAY	51__MAY	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	6	15	15	CD
work_l7e6s5xjjrez3dcffje2smkysi	77	7	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	77	8	2014	2014	CD
work_l7e6s5xjjrez3dcffje2smkysi	77	9	EKAMBARAM	EKAMBARAM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	10	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	77	11	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	12	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	77	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	78	1	LEVAMISOLE	LEVAMISOLE	NNP
work_l7e6s5xjjrez3dcffje2smkysi	78	2	IN	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	78	3	NEPHROTIC	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	78	4	SYNDROME	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	78	5	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	78	6	randomized	randomized	JJ
work_l7e6s5xjjrez3dcffje2smkysi	78	7	controlled	controlled	JJ
work_l7e6s5xjjrez3dcffje2smkysi	78	8	trials	trial	NNS
work_l7e6s5xjjrez3dcffje2smkysi	78	9	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	78	10	10	10	CD
work_l7e6s5xjjrez3dcffje2smkysi	78	11	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	78	12	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	78	13	Durkan	Durkan	NNP
work_l7e6s5xjjrez3dcffje2smkysi	78	14	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	78	15	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	78	16	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	78	17	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	79	1	showed	show	VBD
work_l7e6s5xjjrez3dcffje2smkysi	79	2	that	that	DT
work_l7e6s5xjjrez3dcffje2smkysi	79	3	prolonged	prolong	VBN
work_l7e6s5xjjrez3dcffje2smkysi	79	4	course	course	NN
work_l7e6s5xjjrez3dcffje2smkysi	79	5	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	79	6	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	79	7	reduces	reduce	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	79	8	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	79	9	incidence	incidence	NN
work_l7e6s5xjjrez3dcffje2smkysi	79	10	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	79	11	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	79	12	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	80	1	Various	various	JJ
work_l7e6s5xjjrez3dcffje2smkysi	80	2	studies	study	NNS
work_l7e6s5xjjrez3dcffje2smkysi	80	3	have	have	VBP
work_l7e6s5xjjrez3dcffje2smkysi	80	4	reported	report	VBN
work_l7e6s5xjjrez3dcffje2smkysi	80	5	side	side	JJ
work_l7e6s5xjjrez3dcffje2smkysi	80	6	effects	effect	NNS
work_l7e6s5xjjrez3dcffje2smkysi	80	7	while	while	IN
work_l7e6s5xjjrez3dcffje2smkysi	80	8	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	80	9	alternate	alternate	JJ
work_l7e6s5xjjrez3dcffje2smkysi	80	10	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	11	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	12	schedule	schedule	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	13	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	80	14	though	though	IN
work_l7e6s5xjjrez3dcffje2smkysi	80	15	these	these	DT
work_l7e6s5xjjrez3dcffje2smkysi	80	16	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	80	17	not	not	RB
work_l7e6s5xjjrez3dcffje2smkysi	80	18	life	life	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	19	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	80	20	threatening	threaten	VBG
work_l7e6s5xjjrez3dcffje2smkysi	80	21	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	80	22	were	be	VBD
work_l7e6s5xjjrez3dcffje2smkysi	80	23	reversible	reversible	JJ
work_l7e6s5xjjrez3dcffje2smkysi	80	24	on	on	IN
work_l7e6s5xjjrez3dcffje2smkysi	80	25	discontinuing	discontinuing	JJ
work_l7e6s5xjjrez3dcffje2smkysi	80	26	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	27	[	[	-LRB-
work_l7e6s5xjjrez3dcffje2smkysi	80	28	6,7,9,11	6,7,9,11	NN
work_l7e6s5xjjrez3dcffje2smkysi	80	29	]	]	-RRB-
work_l7e6s5xjjrez3dcffje2smkysi	80	30	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	81	1	We	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	81	2	did	do	VBD
work_l7e6s5xjjrez3dcffje2smkysi	81	3	not	not	RB
work_l7e6s5xjjrez3dcffje2smkysi	81	4	observe	observe	VB
work_l7e6s5xjjrez3dcffje2smkysi	81	5	any	any	DT
work_l7e6s5xjjrez3dcffje2smkysi	81	6	side	side	NN
work_l7e6s5xjjrez3dcffje2smkysi	81	7	effects	effect	NNS
work_l7e6s5xjjrez3dcffje2smkysi	81	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	81	9	even	even	RB
work_l7e6s5xjjrez3dcffje2smkysi	81	10	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	81	11	those	those	DT
work_l7e6s5xjjrez3dcffje2smkysi	81	12	who	who	WP
work_l7e6s5xjjrez3dcffje2smkysi	81	13	completed	complete	VBD
work_l7e6s5xjjrez3dcffje2smkysi	81	14	2	2	CD
work_l7e6s5xjjrez3dcffje2smkysi	81	15	years	year	NNS
work_l7e6s5xjjrez3dcffje2smkysi	81	16	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	81	17	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	81	18	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	81	19	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	81	20	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	82	1	To	to	TO
work_l7e6s5xjjrez3dcffje2smkysi	82	2	conclude	conclude	VB
work_l7e6s5xjjrez3dcffje2smkysi	82	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	82	4	daily	daily	JJ
work_l7e6s5xjjrez3dcffje2smkysi	82	5	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	6	along	along	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	7	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	8	initial	initial	JJ
work_l7e6s5xjjrez3dcffje2smkysi	82	9	low	low	JJ
work_l7e6s5xjjrez3dcffje2smkysi	82	10	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	11	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	12	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	13	can	can	MD
work_l7e6s5xjjrez3dcffje2smkysi	82	14	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	82	15	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	82	16	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	17	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	82	18	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	19	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	82	20	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	82	21	SDNS	sdns	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	22	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	23	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	82	24	better	well	JJR
work_l7e6s5xjjrez3dcffje2smkysi	82	25	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	82	26	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	27	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	82	28	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	82	29	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	82	30	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	83	1	It	-PRON-	PRP
work_l7e6s5xjjrez3dcffje2smkysi	83	2	significantly	significantly	RB
work_l7e6s5xjjrez3dcffje2smkysi	83	3	reduces	reduce	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	83	4	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	83	5	cumulative	cumulative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	83	6	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	83	7	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	83	8	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	83	9	intake	intake	NN
work_l7e6s5xjjrez3dcffje2smkysi	83	10	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	83	11	relapse	relapse	VB
work_l7e6s5xjjrez3dcffje2smkysi	83	12	rates	rate	NNS
work_l7e6s5xjjrez3dcffje2smkysi	83	13	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	84	1	Levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	84	2	can	can	MD
work_l7e6s5xjjrez3dcffje2smkysi	84	3	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	84	4	used	use	VBN
work_l7e6s5xjjrez3dcffje2smkysi	84	5	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	84	6	an	an	DT
work_l7e6s5xjjrez3dcffje2smkysi	84	7	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	84	8	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	84	9	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	84	10	sparing	spare	VBG
work_l7e6s5xjjrez3dcffje2smkysi	84	11	agent	agent	NN
work_l7e6s5xjjrez3dcffje2smkysi	84	12	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	84	13	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	84	14	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	84	15	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	84	16	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	84	17	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	84	18	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	84	19	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	84	20	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	84	21	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	84	22	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	84	23	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	85	1	REFERENCES	reference	NNS
work_l7e6s5xjjrez3dcffje2smkysi	85	2	1	1	CD
work_l7e6s5xjjrez3dcffje2smkysi	85	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	86	1	Davin	Davin	NNP
work_l7e6s5xjjrez3dcffje2smkysi	86	2	JC	JC	NNP
work_l7e6s5xjjrez3dcffje2smkysi	86	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	86	4	Merkus	Merkus	NNP
work_l7e6s5xjjrez3dcffje2smkysi	86	5	MP	MP	NNP
work_l7e6s5xjjrez3dcffje2smkysi	86	6	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	87	1	Levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	87	2	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	87	3	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	87	4	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	87	5	sensitive	sensitive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	87	6	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	87	7	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	87	8	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	87	9	childhood	childhood	NN
work_l7e6s5xjjrez3dcffje2smkysi	87	10	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	87	11	the	the	DT
work_l7e6s5xjjrez3dcffje2smkysi	87	12	lost	lose	VBN
work_l7e6s5xjjrez3dcffje2smkysi	87	13	paradise	paradise	NN
work_l7e6s5xjjrez3dcffje2smkysi	87	14	?	?	.
work_l7e6s5xjjrez3dcffje2smkysi	88	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	88	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	88	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	89	1	2005;20:10	2005;20:10	CD
work_l7e6s5xjjrez3dcffje2smkysi	89	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	89	3	4	4	CD
work_l7e6s5xjjrez3dcffje2smkysi	89	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	90	1	2	2	LS
work_l7e6s5xjjrez3dcffje2smkysi	90	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	91	1	Hodson	Hodson	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	2	EM	EM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	91	4	Craig	Craig	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	5	JC	JC	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	91	7	Willis	Willis	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	8	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	91	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	92	1	Evidence	evidence	NN
work_l7e6s5xjjrez3dcffje2smkysi	92	2	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	92	3	based	base	VBN
work_l7e6s5xjjrez3dcffje2smkysi	92	4	management	management	NN
work_l7e6s5xjjrez3dcffje2smkysi	92	5	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	92	6	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	92	7	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	92	8	sensitive	sensitive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	92	9	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	92	10	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	92	11	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	93	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	93	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	93	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	94	1	2005;20:1523	2005;20:1523	CD
work_l7e6s5xjjrez3dcffje2smkysi	94	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	94	3	30	30	CD
work_l7e6s5xjjrez3dcffje2smkysi	94	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	95	1	3	3	LS
work_l7e6s5xjjrez3dcffje2smkysi	95	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	96	1	Van	Van	NNP
work_l7e6s5xjjrez3dcffje2smkysi	96	2	Husen	Husen	NNP
work_l7e6s5xjjrez3dcffje2smkysi	96	3	M	M	NNP
work_l7e6s5xjjrez3dcffje2smkysi	96	4	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	96	5	Kemper	Kemper	NNP
work_l7e6s5xjjrez3dcffje2smkysi	96	6	MJ	MJ	NNP
work_l7e6s5xjjrez3dcffje2smkysi	96	7	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	97	1	New	new	JJ
work_l7e6s5xjjrez3dcffje2smkysi	97	2	therapies	therapy	NNS
work_l7e6s5xjjrez3dcffje2smkysi	97	3	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	97	4	steroid-	steroid-	XX
work_l7e6s5xjjrez3dcffje2smkysi	97	5	sensitive	sensitive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	97	6	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	97	7	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	97	8	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	97	9	resistant	resistant	JJ
work_l7e6s5xjjrez3dcffje2smkysi	97	10	idiopathic	idiopathic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	97	11	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	97	12	WHAT	what	WP
work_l7e6s5xjjrez3dcffje2smkysi	97	13	IS	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	97	14	ALREADY	ALREADY	NNP
work_l7e6s5xjjrez3dcffje2smkysi	97	15	KNOWN	know	VBN
work_l7e6s5xjjrez3dcffje2smkysi	97	16	?	?	.
work_l7e6s5xjjrez3dcffje2smkysi	98	1	•	•	NNP
work_l7e6s5xjjrez3dcffje2smkysi	98	2	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	98	3	is	be	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	98	4	commonly	commonly	RB
work_l7e6s5xjjrez3dcffje2smkysi	98	5	used	use	VBN
work_l7e6s5xjjrez3dcffje2smkysi	98	6	as	as	IN
work_l7e6s5xjjrez3dcffje2smkysi	98	7	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	98	8	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	98	9	sparing	spare	VBG
work_l7e6s5xjjrez3dcffje2smkysi	98	10	agent	agent	NN
work_l7e6s5xjjrez3dcffje2smkysi	98	11	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	98	12	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	98	13	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	98	14	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	98	15	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	98	16	or	or	CC
work_l7e6s5xjjrez3dcffje2smkysi	98	17	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	98	18	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	98	19	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	98	20	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	98	21	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	99	1	WHAT	what	WP
work_l7e6s5xjjrez3dcffje2smkysi	99	2	THIS	this	DT
work_l7e6s5xjjrez3dcffje2smkysi	99	3	STUDY	study	NN
work_l7e6s5xjjrez3dcffje2smkysi	99	4	ADDS	ADDS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	99	5	?	?	.
work_l7e6s5xjjrez3dcffje2smkysi	100	1	•	•	NNP
work_l7e6s5xjjrez3dcffje2smkysi	100	2	Daily	Daily	NNP
work_l7e6s5xjjrez3dcffje2smkysi	100	3	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	4	along	along	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	5	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	6	initial	initial	JJ
work_l7e6s5xjjrez3dcffje2smkysi	100	7	low	low	JJ
work_l7e6s5xjjrez3dcffje2smkysi	100	8	dose	dose	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	9	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	10	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	11	can	can	MD
work_l7e6s5xjjrez3dcffje2smkysi	100	12	be	be	VB
work_l7e6s5xjjrez3dcffje2smkysi	100	13	effective	effective	JJ
work_l7e6s5xjjrez3dcffje2smkysi	100	14	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	15	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	100	16	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	100	17	SDNS	sdns	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	18	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	100	19	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	20	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	100	21	better	well	JJR
work_l7e6s5xjjrez3dcffje2smkysi	100	22	efficacy	efficacy	NN
work_l7e6s5xjjrez3dcffje2smkysi	100	23	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	24	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	100	25	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	100	26	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	100	27	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	101	1	•	•	VB
work_l7e6s5xjjrez3dcffje2smkysi	101	2	Cumulative	cumulative	JJ
work_l7e6s5xjjrez3dcffje2smkysi	101	3	dosage	dosage	NN
work_l7e6s5xjjrez3dcffje2smkysi	101	4	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	101	5	steroids	steroid	NNS
work_l7e6s5xjjrez3dcffje2smkysi	101	6	reduces	reduce	VBZ
work_l7e6s5xjjrez3dcffje2smkysi	101	7	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	101	8	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	101	9	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	101	10	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	101	11	FRNS	FRNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	101	12	/	/	SYM
work_l7e6s5xjjrez3dcffje2smkysi	101	13	SDNS	SDNS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	101	14	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	102	1	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	102	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	103	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	103	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	103	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	104	1	2011;26:881	2011;26:881	CD
work_l7e6s5xjjrez3dcffje2smkysi	104	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	104	3	92	92	CD
work_l7e6s5xjjrez3dcffje2smkysi	104	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	105	1	4	4	LS
work_l7e6s5xjjrez3dcffje2smkysi	105	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	106	1	Management	Management	NNP
work_l7e6s5xjjrez3dcffje2smkysi	106	2	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	106	3	Steroid	Steroid	NNP
work_l7e6s5xjjrez3dcffje2smkysi	106	4	Sensitive	Sensitive	NNP
work_l7e6s5xjjrez3dcffje2smkysi	106	5	Nephrotic	Nephrotic	NNP
work_l7e6s5xjjrez3dcffje2smkysi	106	6	Syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	106	7	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	106	8	Revised	Revised	NNP
work_l7e6s5xjjrez3dcffje2smkysi	106	9	Guidelines	Guidelines	NNPS
work_l7e6s5xjjrez3dcffje2smkysi	106	10	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	107	1	Indian	Indian	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	2	Pediatric	Pediatric	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	3	Nephrology	Nephrology	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	4	Group	Group	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	5	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	107	6	Indian	Indian	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	7	Academy	Academy	NNP
work_l7e6s5xjjrez3dcffje2smkysi	107	8	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	107	9	Pediatrics	Pediatrics	NNPS
work_l7e6s5xjjrez3dcffje2smkysi	107	10	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	108	1	Indian	Indian	NNP
work_l7e6s5xjjrez3dcffje2smkysi	108	2	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	108	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	109	1	2008;45:203	2008;45:203	CD
work_l7e6s5xjjrez3dcffje2smkysi	109	2	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	109	3	14	14	CD
work_l7e6s5xjjrez3dcffje2smkysi	109	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	110	1	5	5	CD
work_l7e6s5xjjrez3dcffje2smkysi	110	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	111	1	Fu	Fu	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	2	LS	LS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	111	4	Shien	Shien	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	5	CY	CY	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	111	7	Chi	Chi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	8	CS	CS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	111	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	112	1	Levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	2	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	112	3	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	4	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	112	5	sensitive	sensitive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	112	6	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	112	7	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	8	children	child	NNS
work_l7e6s5xjjrez3dcffje2smkysi	112	9	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	112	10	frequent	frequent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	112	11	relapses	relapse	NNS
work_l7e6s5xjjrez3dcffje2smkysi	112	12	and/or	and/or	CC
work_l7e6s5xjjrez3dcffje2smkysi	112	13	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	14	dependency	dependency	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	15	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	112	16	Comparison	comparison	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	17	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	112	18	daily	daily	NNP
work_l7e6s5xjjrez3dcffje2smkysi	112	19	and	and	CC
work_l7e6s5xjjrez3dcffje2smkysi	112	20	every	every	DT
work_l7e6s5xjjrez3dcffje2smkysi	112	21	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	112	22	other-	other-	CD
work_l7e6s5xjjrez3dcffje2smkysi	112	23	day	day	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	24	usage	usage	NN
work_l7e6s5xjjrez3dcffje2smkysi	112	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	113	1	Nephron	Nephron	NNP
work_l7e6s5xjjrez3dcffje2smkysi	113	2	Clin	Clin	NNP
work_l7e6s5xjjrez3dcffje2smkysi	113	3	Pract	Pract	NNP
work_l7e6s5xjjrez3dcffje2smkysi	113	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	114	1	2004;97	2004;97	CD
work_l7e6s5xjjrez3dcffje2smkysi	114	2	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	114	3	c137–c41	c137–c41	UH
work_l7e6s5xjjrez3dcffje2smkysi	114	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	115	1	6	6	CD
work_l7e6s5xjjrez3dcffje2smkysi	115	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	116	1	Madani	Madani	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	2	A	A	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	4	Isfahani	Isfahani	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	5	ST	ST	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	7	Rahimzadeh	Rahimzadeh	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	8	N	N	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	9	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	10	Fereshtehnejad	Fereshtehnejad	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	11	SM	SM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	12	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	13	Hoseini	Hoseini	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	14	R	R	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	15	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	16	Moghtaderi	Moghtaderi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	17	M	M	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	18	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	116	19	et	et	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	20	al	al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	116	21	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	117	1	Effect	effect	NN
work_l7e6s5xjjrez3dcffje2smkysi	117	2	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	117	3	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	117	4	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	117	5	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	117	6	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	117	7	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	117	8	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	117	9	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	117	10	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	118	1	Iran	Iran	NNP
work_l7e6s5xjjrez3dcffje2smkysi	118	2	J	J	NNP
work_l7e6s5xjjrez3dcffje2smkysi	118	3	Kidney	Kidney	NNP
work_l7e6s5xjjrez3dcffje2smkysi	118	4	Dis	Dis	NNP
work_l7e6s5xjjrez3dcffje2smkysi	118	5	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	119	1	2010;4:292	2010;4:292	CD
work_l7e6s5xjjrez3dcffje2smkysi	119	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	119	3	96	96	CD
work_l7e6s5xjjrez3dcffje2smkysi	119	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	120	1	7	7	LS
work_l7e6s5xjjrez3dcffje2smkysi	120	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	121	1	Al	Al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	2	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	121	3	Saran	Saran	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	4	K	K	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	5	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	121	6	Mirza	Mirza	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	7	K	K	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	121	9	Al	Al	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	10	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	121	11	Ghanam	Ghanam	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	12	G	G	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	13	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	121	14	Abdelkarim	Abdelkarim	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	15	M.	M.	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	16	Experience	Experience	NNP
work_l7e6s5xjjrez3dcffje2smkysi	121	17	with	with	IN
work_l7e6s5xjjrez3dcffje2smkysi	121	18	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	121	19	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	121	20	frequently	frequently	RB
work_l7e6s5xjjrez3dcffje2smkysi	121	21	relapsing	relapse	VBG
work_l7e6s5xjjrez3dcffje2smkysi	121	22	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	121	23	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	121	24	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	121	25	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	121	26	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	121	27	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	121	28	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	122	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	122	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	122	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	123	1	2006;21:201	2006;21:201	CD
work_l7e6s5xjjrez3dcffje2smkysi	123	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	123	3	5	5	CD
work_l7e6s5xjjrez3dcffje2smkysi	123	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	124	1	8	8	LS
work_l7e6s5xjjrez3dcffje2smkysi	124	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	125	1	Sumegi	Sumegi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	2	V	V	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	125	4	Haszon	Haszon	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	5	I	I	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	125	7	Ivanyi	Ivanyi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	8	B	B	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	9	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	125	10	Bereczki	Bereczki	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	11	C	C	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	12	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	125	13	Papp	Papp	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	14	F	F	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	15	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	125	16	Turi	Turi	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	17	S.	S.	NNP
work_l7e6s5xjjrez3dcffje2smkysi	125	18	Long	long	JJ
work_l7e6s5xjjrez3dcffje2smkysi	125	19	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	125	20	term	term	NN
work_l7e6s5xjjrez3dcffje2smkysi	125	21	effects	effect	NNS
work_l7e6s5xjjrez3dcffje2smkysi	125	22	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	125	23	levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	125	24	treatment	treatment	NN
work_l7e6s5xjjrez3dcffje2smkysi	125	25	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	125	26	childhood	childhood	NN
work_l7e6s5xjjrez3dcffje2smkysi	125	27	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	125	28	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	125	29	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	126	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	126	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	126	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	127	1	2006;19:1354	2006;19:1354	CD
work_l7e6s5xjjrez3dcffje2smkysi	127	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	127	3	60	60	CD
work_l7e6s5xjjrez3dcffje2smkysi	127	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	128	1	9	9	CD
work_l7e6s5xjjrez3dcffje2smkysi	128	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	129	1	Bagga	Bagga	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	2	A	A	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	129	4	Sharma	Sharma	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	5	A	A	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	129	7	Srivastava	Srivastava	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	8	RN	RN	NNP
work_l7e6s5xjjrez3dcffje2smkysi	129	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	130	1	Levamisole	levamisole	NN
work_l7e6s5xjjrez3dcffje2smkysi	130	2	therapy	therapy	NN
work_l7e6s5xjjrez3dcffje2smkysi	130	3	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	130	4	corticosteroid	corticosteroid	JJ
work_l7e6s5xjjrez3dcffje2smkysi	130	5	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	130	6	dependent	dependent	JJ
work_l7e6s5xjjrez3dcffje2smkysi	130	7	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	130	8	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	130	9	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	131	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	131	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	131	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	132	1	1997;11:415	1997;11:415	CD
work_l7e6s5xjjrez3dcffje2smkysi	132	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	132	3	7	7	CD
work_l7e6s5xjjrez3dcffje2smkysi	132	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	133	1	10	10	CD
work_l7e6s5xjjrez3dcffje2smkysi	133	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	134	1	Durkan	durkan	JJ
work_l7e6s5xjjrez3dcffje2smkysi	134	2	AM	am	NN
work_l7e6s5xjjrez3dcffje2smkysi	134	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	134	4	Hodson	Hodson	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	5	EM	EM	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	6	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	134	7	Willis	Willis	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	8	NS	NS	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	9	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	134	10	Craig	Craig	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	11	JC	JC	NNP
work_l7e6s5xjjrez3dcffje2smkysi	134	12	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	135	1	Immunosuppressive	immunosuppressive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	135	2	agents	agent	NNS
work_l7e6s5xjjrez3dcffje2smkysi	135	3	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	135	4	childhood	childhood	NN
work_l7e6s5xjjrez3dcffje2smkysi	135	5	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	135	6	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	135	7	:	:	:
work_l7e6s5xjjrez3dcffje2smkysi	135	8	a	a	DT
work_l7e6s5xjjrez3dcffje2smkysi	135	9	meta	meta	JJ
work_l7e6s5xjjrez3dcffje2smkysi	135	10	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	135	11	analysis	analysis	NN
work_l7e6s5xjjrez3dcffje2smkysi	135	12	of	of	IN
work_l7e6s5xjjrez3dcffje2smkysi	135	13	randomized	randomized	JJ
work_l7e6s5xjjrez3dcffje2smkysi	135	14	controlled	controlled	JJ
work_l7e6s5xjjrez3dcffje2smkysi	135	15	trials	trial	NNS
work_l7e6s5xjjrez3dcffje2smkysi	135	16	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	136	1	Kidney	Kidney	NNP
work_l7e6s5xjjrez3dcffje2smkysi	136	2	Int	Int	NNP
work_l7e6s5xjjrez3dcffje2smkysi	136	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	137	1	2001;59:1919	2001;59:1919	CD
work_l7e6s5xjjrez3dcffje2smkysi	137	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	137	3	27	27	CD
work_l7e6s5xjjrez3dcffje2smkysi	137	4	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	138	1	11	11	CD
work_l7e6s5xjjrez3dcffje2smkysi	138	2	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	139	1	Tenbrock	Tenbrock	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	2	K	K	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	3	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	139	4	Muller	Muller	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	5	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	139	6	Berghaus	Berghaus	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	7	J	J	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	8	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	139	9	Fuchshuber	Fuchshuber	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	10	A	A	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	11	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	139	12	Michalk	Michalk	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	13	D	D	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	14	,	,	,
work_l7e6s5xjjrez3dcffje2smkysi	139	15	Querfeld	Querfeld	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	16	U.	U.	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	17	Levamisole	Levamisole	NNP
work_l7e6s5xjjrez3dcffje2smkysi	139	18	treatment	treatment	NN
work_l7e6s5xjjrez3dcffje2smkysi	139	19	in	in	IN
work_l7e6s5xjjrez3dcffje2smkysi	139	20	steroid	steroid	NN
work_l7e6s5xjjrez3dcffje2smkysi	139	21	-	-	HYPH
work_l7e6s5xjjrez3dcffje2smkysi	139	22	sensitive	sensitive	JJ
work_l7e6s5xjjrez3dcffje2smkysi	139	23	nephrotic	nephrotic	JJ
work_l7e6s5xjjrez3dcffje2smkysi	139	24	syndrome	syndrome	NN
work_l7e6s5xjjrez3dcffje2smkysi	139	25	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	140	1	Pediatr	Pediatr	NNP
work_l7e6s5xjjrez3dcffje2smkysi	140	2	Nephrol	Nephrol	NNP
work_l7e6s5xjjrez3dcffje2smkysi	140	3	.	.	.
work_l7e6s5xjjrez3dcffje2smkysi	141	1	1998;12:459	1998;12:459	CD
work_l7e6s5xjjrez3dcffje2smkysi	141	2	-	-	SYM
work_l7e6s5xjjrez3dcffje2smkysi	141	3	62	62	CD
work_l7e6s5xjjrez3dcffje2smkysi	141	4	.	.	.